A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients-Reference-Cited by-同舟云学术

A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients

Published:2008-03 Issue:3 Volume:19 Page:309-315
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Validire Patricia,Fermé Christophe,Brice Pauline,Diviné Marine,Gabarre Jean,Bouabdallah Krimo,Fitoussi Olivier,Chaoui Driss,Pacquement Hélène,Soussain Carole,Carde Patrice,Salhi Rafika,Zanni Manuela,Decaudin Didier

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference35 articles.

1. The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease;Rosenberg;Int J Radiat Oncol Biol Phys,1985

2. Hodgkin's disease;Urba;N Engl J Med,1992

3. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD;Canellos;N Engl J Med,1992

4. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's disease lymphoma: interim report from a trial of the German Hodgkin's lymphoma Study Group;Diehl;J Clin Oncol,1998

5. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure;Longo;J Clin Oncol,1992

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brentuximab vedotin in pretreated Hodgkin lymphoma patients: a systematic review and meta-analysis;Expert Opinion on Biological Therapy;2016-05-03

2. Brentuximab vedotin compared with other therapies in relapsed/refractory Hodgkin lymphoma post autologous stem cell transplant: median overall survival meta-analysis;Current Medical Research and Opinion;2015-06-03

3. Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous transplant: meta-analysis versus historical data;Current Medical Research and Opinion;2015-04-09

4. Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma;OncoTargets and Therapy;2014-11

5. Changing therapeutic landscape – The last decade;Transfusion and Apheresis Science;2011-04